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Abstract
Objective. The purpose of this study was to determine whether the combined use of diffusion weighted imaging (DWI), mag-
netic resonance spectroscopy (MRS), and dynamic susceptibility contrast imaging (DSCI) parameters could provide a more 
accurate diagnosis in the differentiation of high-grade glioma (HGG) from solitary brain metastasis (SBM) in the enhancing 
tumour and in the peritumoural region.
Materials and methods. Fifty-six patients who received DWI, DSCI, and MRS before surgery were assessed. In differentiating 
SBM from HGG, the cutoff values of the DWI-apparent diffusion coefficient (ADCmin, ADCmax, and ADCmean), DSCI-relative 
cerebral blood volume (rCBV), and MRS-Cho/Cr, Cho/NAA, and NAA/Cr parameters for the peritumoural region were determined 
with ROC. The combined ROC curve was used for the different combinations of the peritumoural region DWI, DSCI, and MRS 
parameters in differentiating between the two tumours, and the best model combination was formed. 
All procedures performed in studies involving human participants were in accordance with the ethical standards of the insti-
tutional research committee and with the 1964 Helsinki Declaration and its later amendments. This study was approved by the 
Institutional Review Board at our institutes.
Results. In the enhancing tumour, all the parameters except NAA/Cr (P = 0.024) exhibited no statistical difference in differentia-
ting between these two groups (P > 0.05). AUC values for ADCmin, ADCmax, ADCmean, rADCmin, rADCmax, rADCmean, rCBV, 
Cho/Cr, Cho/NAA, and NAA/Cr parameters in the peritumoural region in differentiating SBM from HGG were 0.860, 0.822, 0.848, 
0.822, 0.801, 0.822, 0.906, 0.851, 0.903, and 0.784, respectively. In differentiating HGG from SBM, the best model consisted of the 
combination of peritumoural ADCmin, rCBV, and Cho/NAA parameters. AUC values were 0.970.
Conclusions. The combination of peritumoural region ADCmin, rCBV, and Cho/NAA parameters can help in differentiating SBM 
from HGG, with a diagnostic accuracy of 97%.
Key words: Solitary brain metastasis, high-grade glioma, diffusion-weighted imaging, dynamic susceptibility contrast  
imaging, magnetic resonance spectroscopy 
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Introduction
High-grade glial (HGG) tumours and brain metastases 
are the most frequently diagnosed brain tumours in adults. 
In the diagnosis of brain metastasis, primary malignancy 
history, multiple lesions, and the combined localisation of 
grey–white substance are helpful. However, in patients with 
primary malignancy, HGG can occur and can sometimes be 
multiple. In almost 30% of extracranial malignancies, the 
first manifestation of the disease can be solitary brain me-
tastasis (SBM) [1, 2]. As SBM and HGG usually have similar 
signal intensities and contrasting patterns in conventional 
magnetic resonance imaging (MRI), MRI can be inade-
quate in differentiating between these two tumours [3, 4]. 
Treatment planning, follow up, and prognosis are different 
between SBM and HGG. In patients with malignancy, an 
enhancing brain lesion may not only be treated by surgical 
resection but also by radiotherapy since such a lesion may of-
ten be judged to be a metastasis without a histopathological 
assessment. In such cases, image-based differentiation could 
play an important role in the treatment choice. Therefore, 
reliable imaging is important in differentiating between 
these two tumours. 
Whereas HGG has infiltrative neoplastic cells in the 
peritumoural oedema, the peritumoural region of SBM is 
characterised by vasogenic oedema depending on the increase 
in capillary permeability. Therefore, determining these chan-
ges in the peritumoural region is crucial in differentiating 
HGG from SBM. Apart from conventional MRI, advanced 
MR imaging modalities such as diffusion-weighted MRI 
(DWI), MR spectroscopy (MRS), and dynamic susceptibility 
perfusion MRI (DSCI) are used to identify these changes in 
the peritumoural region by providing quantitative measure-
ments. Apparent diffusion coefficient (ADC) obtained from 
DWI provides information on the cellularity of the tissue 
by measuring independently from the direction of the total 
magnitude of water diffusion in the tissue. Some studies have 
shown that low ADC values are associated with high cellularity 
in the peritumoural region in HGG compared to SBM [5–14] 
Suh et al. [15] reported that DWI and diffusion tensor imaging 
(DTI) demonstrated a moderate diagnostic performance for 
the differentiation of high-grade glioma from solitary brain 
metastasis. Choline (Cho) metabolite in MRS reflects cellular 
density and the rate of cellular membrane turnover. Studies 
on MRS have shown increases in Cho/creatine (Cr) and 
Cho/N-acetyl aspartate (NAA) in the peritumoural region 
infiltration in HGG tumours, and reported that these incre-
ases could be used in differentiating them from metastases 
[16–20]. The relative cerebral blood volume (rCBV) obtained 
from DSCI provides a quantitative assessment of neovascula-
risation based on the tumour infiltration in the peritumoural 
region. Some studies have indicated that the high rCBV values 
associated with neovascularisation in the peritumoural region 
in HGG could be useful in differentiating between these two 
tumours [21–25]. Suh et al. [26] reported that perfusion MRI 
shows high diagnostic performance in differentiating glioma 
from brain metastasis.
Some studies have used advanced MR modalities in diffe-
rentiating SBM from HGG [27–31]. However, none of these 
works examined the difference between SBM and HGG by 
using a combination of these modalities. Recently, researchers 
have examined the uses of different combinations of advanced 
MRI techniques in differentiating between these two tumours. 
Some of these studies have shown that the combinations of 
diffusion and perfusion parameter measurements could be 
helpful in differentiating between these two tumours [32–35]. 
Tsolaki et al. [36] combined MRS and perfusion techniques 
with machine learning methods in differentiating between 
glioblastomas and solitary metastases, and reported that 
they provided additional diagnostic information in definitive 
diagnosis. Mouthuy et al. [37] showed that multimodal MRI 
parameters (perfusion–rCBV, texture parameter contrast, 
and sum average) could be useful in differentiating between 
SBM and HGG. Tsougos et al. [38] reported that the MRS and 
DSCI measurements of the peritumoural region could help 
differentiate between glioblastomas and metastases, whereas 
diffusion parameters could not statistically differentiate be-
tween the two lesions. 
The purpose of this study was to determine whether 
the combined use of the DWI [minimum (ADCmin), mean 
(ADCmean), and maximum (ADCmax) ADC and minimum 
(rADCmin), mean (rADCmean), and maximum (rADCmax) 
ADC ratio], MRS (Cho/Cr, Cho/NAA, and NAA/Cr) and DSCI 
(rCBV) parameters could provide a more accurate diagnosis in 
differentiating SBM from HGG in the enhancing tumour and 
in the peritumoural region. Our purpose was also to reveal 
the diagnostic accuracy of both parameters in differentiating 
between these two tumours. 
Materials and methods
Patients
This study was approved by the local ethics committee of 
our institution (OMÜ KAEK 2017/153). Preoperative MRI 
and clinical records of 86 consecutive patients who were 
referred to our hospital between March 2012 and December 
2016 and who were diagnosed with brain metastasis and HGG 
histopathological were examined retrospectively. Several 
patients were excluded: two patients who had pre-resection 
stereotactic biopsy, two patients who had been treated, 11 pa-
tients who did not have a solitary lesion (HGG, n = 2 and BM, 
n = 9), four patients who did not have a peritumoural oedema 
in the lesion, and five patients who did not receive DWI, DSCI, 
and MRS. Patients with a lesion size smaller than 2 cm were 
also excluded from the study (n = 6). So eventually, 56 pa-
tients who did not receive pre-resection stereotactic biopsy 
and treatment, who had a solitary enhancing brain tumour 
and peritumoural oedema, and who received conventional 
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brain MRI, DWI, MRS, and DSCI were included in the study. 
The final diagnosis included 39 HGG (19 men, 20 women; 
mean age: 61.2 ± 10.5 years; range: 37–81 years) and 17 SBM 
(nine men, eight women; mean age: 61.0 ± 13.8 years; range: 
29–83 years). 
In 39 patients, the tumours were classified as HGG, in-
cluding 11 with World Health Organisation (WHO) grade 
III (eight anaplastic astrocytoma and three anaplastic oligo-
dendrogliomas) and 28 with WHO grade IV (glioblastomas) 
according to the WHO criteria. Metastatic brain tumours 
included lung carcinoma (n = 9), breast carcinoma (n = 3), 
melanoma (n = 1), renal carcinoma (n = 1), colon carcinoma 
(n = 1), ovarian carcinoma (n =1), and carcinoma of unknown 
origin (n = 1). 
MR image acquisition
MRI imaging was performed using a 1.5-T scanner (Gyro-
scan Intera, Philips Healthcare, Best, the Netherlands) with an 
eight-channel head coil. Conventional MR imaging sequences, 
DWI, DSCI, and multivoxel MRS imaging were performed on 
all patients. Conventional MRI protocols included pre-contrast 
axial T1-weighted sequence (repetition time [TR]/echo time 
[TE]: 450/15 ms; slice thickness: 5 mm; field of view [FOV]: 
230 mm; matrix: 256 × 163; number of excitations [NEX]: 2; 
intersection gap: 1 mm), axial T2-weighted sequence (TR/TE: 
4,443/100 ms; section thickness: 5 mm; FOV: 230 mm; matrix: 
384 × 240; NEX: 3; intersection gap: 1 mm), coronal fluid at-
tenuation inversion recovery (TR/TE/TI: 8,000/140/2,800 ms; 
section thickness: 5 mm; FOV: 230 mm; matrix: 224 × 148; 
NEX: 2; intersection gap: 0.4 mm), sagittal T2-weighted se-
quence (TR/TE: 4,027/100 ms; section thickness: 5 mm; FOV: 
230 mm; matrix: 236 × 205; NEX: 2; intersection gap: 1 mm).
DWI was performed with a single-shot spin-echo EPI 
(TR/TE: 3,376/74 ms; section thickness: 5 mm; FOV: 230 mm; 
matrix: 128 × 128; NEX: 2; intersection gap: 1 mm; b values: 
0 and 1,000 s/mm2). 
DSCI was conducted using a single-shot spin-echo EPI 
sequence (TR/TE: 1,524/40 ms; section thickness: 5 mm; 
FOV: 230 mm; matrix: 128 × 128; NEX: 2; no gap; voxel size: 
2.0 mm x 2.0 mm x 5.0 mm). All of the patients were given 
intravenous gadobutrol (0.05 mmol/kg, 1.0 mmol/mL, Gado-
vist; Bayer Schering Pharma, Berlin, Germany) in a preloading 
dose to decrease pre-dynamic imaging contrast agent leakage. 
DSCI was performed during the first pass of the standard 
dose (0.1 mmol/kg) bolus of an intravenous contrast agent 
(gadobutrol). The injection rate was 5 mL/s for all patients and 
was followed by a 20mL flush of saline at the same rate given 
through a power injector. Following the contrast injection, 
a post-contrast 3D T1-weighted sequence was performed 
(TR/TE: 500/4 ms; NEX: 1; slice thickness: 1 mm; no gap; 
in-plane resolution: 1 mm; FOV: 240 mm; voxel size: 1.0 mm 
x 1.0 mm x 1.0 mm). 
MRS was conducted after contrast injection in all pa-
tients. For MRS imaging, a 3D multivoxel PRESS sequence 
was performed (automatic shimming and Gaussian water 
suppression; TR/TE: 988/144 ms; section thickness: 5 mm; 
FOV: 180 x 160 mm; matrix: 180 x 160; NEX: 2). The volume 
of interest (VOI) was chosen from the tumour, peritumoural 
region, and contralateral normal-appearing white matter, 
avoiding the scalp, skull base, and the sinuses. Saturation slabs 
were placed outside the VOI to suppress lipid signals from the 
scalp. VOI position was determined by examining the MR 
images in three plans (sagittal, coronal, and transverse). The 
size of the VOI differed according to the sizes of the lesions, 
and the most frequent was 80 x 80 mm. The voxel size was 
10 × 10 × 10–15 mm. 
Image analysis
All conventional MRI, DWI, DSCI, and MRS datasets 
were transferred to an independent workstation (IntelliSpace, 
software version v6.0.4.03700, Philips). Two neuroradiologists 
(K.A. and H.P.G., both with six years of experience) were 
unaware of the clinical and pathological results of the pa-
tients, and were completely independent of each other in the 
measurement of the DWI (ADCmin, ADCmax, ADCmean, 
rADCmin, rADCmax, and rADCmean), DSCI (rCBV), and 
MRS (Cho/Cr, Cho/NAA, and NAA/Cr) parameters with the 
regions of interest (ROIs). 
ADC maps were acquired from DWI. ROIs were drawn 
manually in round or oval shapes in solid portions by avoi-
ding the cystic, necrotic and calcified areas of lesions from 
ADC maps. These areas were identified in T2-weighted and 
contrast-enhanced T1W images. The peritumoural region was 
defined as the 1 cm T2 and FLAIR hyperintense area outside 
the contrasted area. Circular ROIs, which were drawn at 
workstations manually to lesions from T2-weighted images, 
were placed automatically to lesions on ADC maps with the 
same localisation and size. The peritumoural and tumoural 
ADC ratios were calculated by dividing the average ADCmin, 
ADCmax, ADCmean values of the peritumoural area and 
contrasted solid tumour by the average normal white matter 
ADCmin, ADCmax, and ADCmean values.
The arterial input function was selected automatically, 
and the CBV maps were calculated using the block-circulant 
singular value decomposition technique for DSCI [39]. CBV 
maps were formed for analysis at the workstation from DSCI 
perfusion datasets. The CBV maps were then coregistered to 
contrast-enhanced 3D T1-weighted images for the enhancing 
tumour and T2-weighted images for the peritumoural region. 
For the CBV measurements, ROIs were manually drawn by 
avoiding cerebral blood vessels, calcifications, haemorrhage, 
and cerebrospinal fluid-filled sulci areas. ROIs were placed 
carefully on each selected section of the CBV maps, including 
the areas of the enhancing tumour and the peritumoural 
region, with the highest CBV determined by visual inspec-
tion. The CBV values for the enhancing tumour and the 
peritumoural region were calculated. The peritumoural and 
enhancing tumour rCBV was determined by dividing the 
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average CBV values of the peritumoural area and enhancing 
tumour by the average CBV values of the lesion level of the 
contralateral normal area. 
The 3D multivoxel PRESS spectroscopic data analysis 
and the calculation of the metabolite ratios were conducted 
at the workstation. The post-processing steps, including 
the frequency shift, baseline correction phase correction, 
and peak fitting/analysis, were performed automatically. 
The spectra were automatically analysed for the relative 
signal intensities (areas under the fitted peaks in the time 
domain) of metabolites. The maximum values of Cho/Cr and 
Cho/NAA ratios and the minimum NAA/Cr ratios were 
obtained from the spectral maps of three localisations (en-
hancing tumour, peritumoural region, and normal appearing 
white matter). Cystic or necrotic, calcific, and haemorrha-
gic areas of the tumour were avoided when choosing the 
voxel. To minimise the partial volume effect, the voxel was 
chosen without including the neighbouring peritumoural 
region as much as possible for the enhancing tumour and 
for the peritumoural region without including the T2 and 
FLAIR hyperintensity outside the peritumoural area and 
the enhancing tumour.
Statistical analysis 
Statistical analyses were performed using the Statisti-
cal Package for the Social Sciences (IBM SPSS Statistics 
version 21; IBM, Armonk, NY, USA). Data were presented 
as the mean (SD), median (min–max), or frequency (%). 
To identify the differences between SBM and HGG in the 
enhancing tumour and the peritumoural region, we used 
Student’s t-test for normally distributed data (age, ADCmin, 
ADCmax, ADCmean, rADCmin, rADCmax, rADCmean, 
rCBV, Cho/Cr, Cho/NAA, and NAA/Cr). The frequencies 
were compared using the continuity correction χ2. AUC was 
evaluated as the measure of a diagnostic test’s discriminatory 
power. For the differentiation between SBM and HGG in the 
peritumoural region, the optimum cutoff values of the DWI 
(ADCmin, ADCmax, ADCmean, rADCmin, rADCmax, and 
rADCmean), DSCI (rCBV), and MRS (Cho/Cr, Cho/NAA, 
and NAA/Cr) parameters were determined using the ROC 
curve. The combined ROC curves were used for the com-
bination of the peritumoural region DWI, DSCI, and MRS 
parameters in differentiating between the two tumours. The 
sensitivity, specificity, positive predictive value (PPV), and 
negative predictive value (NPV) were also identified. The 
AUC was calculated for the ROC curve of each individual 
classifier and for the combined ROC curves. The best model 
combination was then formed. The inter-observer agreement 
between two readers was assessed using weighted Cohen κ 
statistics. A κ value of 0.4 or lower indicates poor agreement; 
0.41–0.60, moderate agreement; 0.61–0.80, good agreement; 
and 0.81–1.0, excellent agreement. A P value < 0.05 was 
considered significant.
Results
Figures 1 and 2 present the samples of our multiparametric 
MRI in patients with HGG and SBM, respectively. 
The ADCmin, ADCmax, ADCmean, rADCmin, rADC-
max, and rADCmean values and the NAA/Cr rates of HGG 
in the peritumoural region were significantly lower than those 
of SBM (P  < 0.001, P  < 0.001, P < 0.001, P < 0.001, P < 0.001, 
P < 0.001, and P = 0.009, respectively), and the rCBV, Cho/Cr, 
and Cho/NAA rates were significantly higher (P < 0.001). 
However, in the enhancing tumour, all the parameters except 
NAA/Cr (P = 0.024) exhibited no statistical differences in 
differentiating between these two groups (P > 0.05). The 
quantitative values, which include the mean ± SD and me-
dian (min-max) of all the parameters (ADCmin, ADCmax, 
ADCmean, rADCmin, rADCmax, rADCmean, rCBV, Cho/Cr, 
Cho/NAA, and NAA/Cr) in the enhancing tumour and the 
peritumoural region, the statistical analyses, and the κ coef-
ficient values are summarised in Table 1 (enhancing tumour) 
and Table 2 (peritumoural region). 
Table 3 presents the cutoff, sensitivity, specificity, PPV, 
NPV, and AUC values for each parameter in the peritumoural 
region in differentiating SBM from HGG. Figures 3A, 3B, and 
3C illustrate the ROC curve analysis results for all the parame-
ters. Of all the parameters, rCBV had the highest individual 
distinctive power, with an AUC of 0.906.
Table 4 shows the sensitivity, specificity, PPV, NPV, and 
AUC values of the different combinations of DWI, DSCI, 
and MRS parameters used in differentiating SBM from HGG. 
Figure 4 illustrates the ROC curve analysis results for the 
combinations of the DWI, DSCI, and MRS parameters. In 
differentiating between these two tumours, any one of the 
model combinations (Fig. 4) was superior to using any indi-
vidual DWI, DSCI, and MRS parameter (Fig. 3A, B). The best 
model in differentiating SBM from HGG was the combination 
of ADCmin, rCBV, and Cho/NAA parameters, and the sens-
itivity, specificity, PPD, NPD, and AUC values were 94.1%, 
100%, 100%, 97.4%, and 0.970, respectively.
Discussion
Our study showed that the individual use of any of the 
peritumoural DWI, DSCI, and MRS parameters can help 
differentiate SBM from HGG. HGG was distinguished from 
SBM in the peritumoural region using the ROC analysis. Any 
model combination was found to be superior to any individual 
DWI, DSCI, and MRS parameter, and the best model was the 
combination of the peritumoural ADCmin, rCBV and Cho/
NAA parameters, with an AUC of 0.970. Our results indicate 
that peritumoural DWI, DSCI, and MRS parameter combi-
nations can better explain the following hypothesis: HGG is 
spread by infiltration into the peritumoural area, whereas 
peritumoural oedema is mainly composed of vasogenic oe-
dema in metastases.
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The enhancing areas of both HGG and SBM are hete-
rogeneous because of necrosis, haemorrhage, and vascular 
proliferation, and the normal parenchymal microstructure can 
be impaired. On the other hand, the peritumoural region is 
homogeneous because of the absence of necrosis and haemorr-
hage, and microstructural structure is relatively maintained 
[35, 40, 41]. In parallel with this, our results showed that in 
the enhancing tumour, all the parameters except NAA/Cr 
(P = 0.024) were not statistically different in differentiating 
HGG from SBM (P > 0.05).
DWI
The present study showed that the ADCmin, ADCmax, 
ADCmean, rADCmin, rADCmax, and rADCmean values 
of HGG in the peritumoural region are statistically low 
(for all ADC parameters, P < 0.001) compared to those of SBM, 
and these results are consistent with those of other studies 
[5-14]. Studies have reported that the peritumoural ADCmin 
values were superior to the ADCmax and ADCmean values 
in differentiating SBM from HGG [5, 13]. Similarly, our study 
found that the peritumoural ADCmin value (AUC:0.860) had 
greater diagnostic accuracy than the ADCmax (AUC:0.822), 
ADCmean (AUC:0.848), rADCmin (AUC:0.822), rADCmax 
(AUC:0.801), and rADCmean (AUC:0.822) values in differen-
tiating SBM from HGG. In differentiating between these two 
tumours, sensitivity was 82.4%, specificity was 89.7%, PPV was 
77.8%, and NPV was 92.1% when the peritumoural ADCmin 
cutoff value was 1.32. Only a few studies have reported that 
the peritumoural ADC values were not statistically different 
between HGG and SBM [10, 38]. 
Tumour ADC (min, max, and mean) and rADC (min, 
max, and mean) did not show a statistical difference between 
HGG and SBM in our study (P > 0.05). These results were in 
accordance with the results of previous studies reporting that 
tumour ADC values are not useful in differentiating SBM from 
HGG [5–9, 11, 12]. However, some studies have shown that 
tumoural ADC values could help to differentiate SBM from 
HGG [10, 14, 28, 33, 34]. The inconsistencies among studies 
that included ADC values in the differentiation between 
these two tumours could be secondary to the differences 
in the underlying tumour histology and different degrees 
of tumour heterogeneity in the contrasted area caused by 
necrosis, calcification, and haemorrhage. The results of this 
study support the hypothesis that peritumoural ADC values 
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Table 1. DWI, MRS, DSCI parameter values for the enhancing tumour in SBM and HGG
Parameter Solitary Brain Metastasis High-grade Glioma p value κ
Mean ± SD Median (min-max) Mean ± SD Median (min-max)
ADCmin 0.83 ± 0.20 0.81 (0.56–1.31) 0.85 ± 0.15 0.82 (0.59–1.39) > 0.05 0.856
ADCmax 1.08 ± 0.21 1.00 (0.82–1.62) 1.09 ± 0.16 1.05 (0.88–1.69) > 0.05 0.911
ADCmean 0.95 ± 0.20 0.92 (0.70–1.42) 0.97 ± 0.15 0.94 (0.70–1.40) > 0.05 0.814
rADCmin 1.16 ± 0.28 1.12 (0.78–1.81) 1.18 ± 0.21 1.13 (0.81–1.92) > 0.05 0.713
rADCmax 1.37 ± 0.26 1.27 (1.04– 2.06) 1.38 ± 0.21 1.34 (1.11–2.15) > 0.05 0.798
rADCmean 1.21 ± 0.26 1.17 (0.89–1.80) 1.24 ± 0.19 1.24 (0.89–1.78) > 0.05 0.756
rCBV 3.68 ± 1.40 3.24 (1.88–7.41) 3.63 ± 1.40 3.29 (1.65–8.07) > 0.05 0.895
Cho/Cr 4.42 ± 2.44 3.67 (1.57–11.26) 3.55 ± 1.71 3.12 (1.23–9.68) > 0.05 0.969
Cho/NAA 3.15 ± 1.89 2.97 (0.77–8.11) 3.49 ± 1.77 3.03 (1.46–10.12) > 0.05 0.971
NAA/Cr 1.48 ± 0.51 1.54 (0.44–2.51) 1.08 ± 0.49 1.01 (0.27–2.08) = 0.024 0.922
*Except for the p-values, and κ coefficient (κ); minimum, maximum, and mean apparent diffusion coefficient (ADCmin, ADCmax, and ADCmean), cerebral blood volume (rCBV), Choline/creatine (Cho/Cr), 
Choline/N-acetyl aspartate (Cho/NAA), and N-acetyl aspartate/creatine (NAA/Cr)
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can determine neoplastic cell infiltration in the peritumoural 
oedema in HGG.  
CBV
In this study, rCBV was higher in the peritumoural region 
in HGG than that in SBM (peritumoural rCBV was 1.14 and 
0.39 for HGG and SBM, respectively, P < 0.001). This result is 
similar to those in previous studies [21–25, 32]. In addition, 
no significant difference was found in the tumour rCBV va-
lues between HGG and SBM (tumoural rCBV was 3.63 and 
3.68 for HGG and SBM, respectively, P = 0.151). This result 
is consistent with those in previous studies reporting that tu-
mour rCBV values are not useful in differentiating SBM from 
HGG [21–25, 32, 33]. When the peritumoural rCBV cutoff 
Table 2. DWI, MRS, DSCI parameter values for the peritumoural region in SBM and HGG*
Parameter Solitary Brain Metastasis High-grade Glioma p value κ
Mean ± SD Median (min-max) Mean ± SD Median (min-max)
ADCmin 1.47 ± 0.16 1.45 (1.17–1.78) 1.12 ± 0.18 1.11 (0.70–1.51) < 0.001 0.926
ADCmax 1.61 ± 0.17 1.59 (1.27–1.90) 1.31 ± 0.22 1.30 (0.82–1.88) < 0.001 0.872
ADCmean 1.52 ± 0.16 1.51 (1.19–1.81) 1.20 ± 0.21 1.19 (0.74–1.69) < 0.001 0.894
rADCmin 1.85 ± 0.22 1.85 (1.44–2.26) 1.43 ± 0.25 1.41 (0.87–1.91) < 0.001 0.764
rADCmax 2.05 ± 0.22 2.02 (1.62–2.42) 1.67 ± 0.28 1.65 (1.05–2.38) < 0.001 0.685
rADCmean 1.93 ± 0.20 1.91 (1.51–2.30) 1.52 ± 0.28 1.51 (0.94–2.15) < 0.001 0.712
rCBV 0.39 ± 0.18 0.39 (0.05–0.74) 1.14 ± 0.46 1.13 (0.47–2.53) < 0.001 0.822
Cho/Cr 1.05 ± 0.21 1.05 (0.66–1.44) 1.79 ± 0.26 1.72 (0.88–2.68) < 0.001 0.952
Cho/NAA 0.72 ± 0.21 0.69 (0.46–1.22) 1.72 ± 0.22 1.70 (1.46–2.54) < 0.001 0.965
NAA/Cr 1.69 ± 0.51 1.67 (0.87–2.81) 1.26 ± 0.41 1.21 (0.63–2.47) = 0.009 0.928
*Except for the p-values, and κ coefficient (κ); minimum, maximum, and mean apparent diffusion coefficient (ADCmin, ADCmax, and ADCmean), cerebral blood volume (rCBV), Choline/creatine (Cho/Cr), 
Choline/N-acetyl aspartate (Cho/NAA), and N-acetyl aspartate/creatine (NAA/Cr)
Table 3. Cutoff, sensitivity, specificity, PPV, NPV, and AUC values in differentiating between SBM and HGG in the peritumoural region with ROC 
Parameter Cutoff Sensitivity Specificity PPV NPV AUC
ADCmin 1.32 82.4%  89.7%  77.8% 92.1% 0.860
ADCmax 1.48 82.4%  82.1%  66.7% 91.4% 0.822
ADCmean 1.44 82.4%  87.2%  73.7% 91.9% 0.848
rADCmin 1.67 82.4%  82.1%  66.7% 91.4% 0.822
rADCmax 1.86 82.4%  76.9%  60.8% 90.9% 0.801
rADCmean 1.79 82.4%  82.1%  66.7% 91.4% 0.822
rCBV 0.61 94.1% 87.2% 76.2% 97.1% 0.906
Cho/Cr 1.29 88.2%  82.1% 68.2% 94.1% 0.851
Cho/NAA 0.99 88.2%  92.3% 83.3% 94.7% 0.903
NAA/Cr 1.33 %82.4 74.4% 58.3% 90.6% 0.784
Area under the curve (AUC), minimum, maximum, and mean apparent diffusion coefficient (ADCmin, ADCmax, and ADCmean), cerebral blood volume (rCBV), Choline/creatine (Cho/Cr), Choline/N-acetyl 
aspartate (Cho/NAA), N-acetyl aspartate/creatine (NAA/Cr), positive predictive value (PPV), and negative predictive value (NPV) 
Table 4. Sensitivity, specificity, PPV, NPV, and AUC values by using the combination of DWI, MRS, and DSCI parameters in differentiating between SBM and 
HGG in the peritumoural region with ROC 
Models AUC Sensitivity Specificity PPV NPV
ADCmin+ rCBV 0.932 94.1%  92.1%  84.2%  97.2% 
ADCmin+ Cho/NAA 0.941 88.2%  100%  100%  95.0% 
rCBV+ Cho/NAA 0.941 88.2%  100%  100%  95.0% 
ADCmin+ rCBV +Cho/NAA 0.970 94.1%  100%  100%  97.4% 
Area under the curve (AUC), minimum apparent diffusion coefficient (ADCmin), cerebral blood volume (rCBV), Choline/N-acetyl aspartate (Cho/NAA), positive predictive value (PPV), and negative predictive 
value (NPV) 
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value was set to 0.61 in differentiating between these two 
tumours, sensitivity was 94.1%, specificity was 87.2%, PPV 
was 76.2%, and NPV was 97.1%. In differentiating between 
these two lesions, the highest individual power among all 
the parameters was rCBV, with an AUC of 0.906. Therefore, 
rCBV seems to be the best individual parameter to determine 
peritumoural invasion. 
The rCBV rates, which are the biological indicator of 
angiogenesis obtained from peritumoural areas, showed pure 
vasogenic oedema in SBM despite exhibiting neoangiogenesis 
in HGG. Therefore, perfusion analysis of the peritumoural 
areas with DSCI can be considered reliable in differentiating 
between the two tumours. 
MRS
The significant increase in peritumoural Cho/Cr 
[17, 18, 27, 28, 38] and Cho/NAA [18, 38, 42] rates of HGG 
compared to those of SBM (P < 0.001 for both) and the 
significant decrease in NAA/Cr [17, 37] rates (P = 0.009) in 
our study were similar to those in previous works. However, 
some studies have reported no significant differences in the 
peritumoural NAA/Cr rates between these two tumours 
[27, 28]. These results show the decrease in NAA based on 
neuron loss, which is a clear effect of peritumoural invasion 
in HGG, and the increase in total choline and Cho/NAA rates. 
These changes are not observed in the peritumoural regions 
of SBM [43, 44]. 
In the present study, a significant increase was reported in 
the NAA/Cr rates in the enhancing tumour in SBM compared 
to that in HGG (P = 0.024). The reason for this increase is 
probably the Cr deficiency in metastasis reported in previous 
studies [16] and the negative correlation between tumour 
infiltration degree and total tumour NAA [45]. This result is 
inconsistent with those of Law et al. [27] and Tsougos et al. 
[38], but is consistent with that of Server et al. [18] 
No significant difference was found in the enhancing 
tumour Cho/Cr rates between HGG and SBM (P = 0.216), 
consistent with previous studies [28, 38, 42]. However, some 
studies have shown that the enhancing tumour Cho/Cr rates 
were lower in HGG than in SBM, and that this could be due 
to necrosis [18, 27]. In the present study, no significant dif-
ference was found in the enhancing tumour Cho/NAA rates 
between HGG and SBM (P = 0.358). This result agrees with 
those of previous studies [17, 38, 42]. The sensitivity and 
specificity values of peritumoural Cho/Cr, Cho/NAA, and 
NAA/Cr rates in differentiating HGG from SBM were 88.2% 
and 82.1%; 88.2% and 92.3%; and 82.4% and 74.4%, respec-
tively. The highest individual power in all MRS parameters in 
differentiating between these two lesions was peritumoural 
Cho/NAA with an AUC of 0.903. This result is consistent was 
those of other studies [18, 38]. It also supports the finding in 
other studies that the Cho/NAA rate is associated with the 
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ROC analysis
We hypothesised that in differentiating HGG from SBM, 
advanced MRI techniques such as DWI, DSCI, and MRS, 
which can explain increased cellularity, density, and neoan-
giogenesis based on infiltration in the peritumoural region, 
could be closely associated with complicated and non-linear 
methods. Therefore, a combination of these MRI techniques 
could result in greater diagnostic accuracy. As each advanced 
MRI parameter can give limited information about the peritu-
moural region characteristic of the tumour (cellularity, density, 
and neo-angiogenesis), it can be insufficient in differentiating 
these two tumours. 
A combination of multiple parameters can provide great 
diagnostic accuracy to differentiate between these two tumo-
urs. Recently, some researchers have examined the advantages 
of different combinations of advanced MRI techniques in 
differentiating SBM from HGG. Svalos et al. [32] combined 
diffusion (ADC and FA) and perfusion (rCBV) techniques 
with classification methods in differentiating glioblastomas and 
metastases from atypical meningiomas, and they reported that 
this combination provided additional diagnostic information in 
definitive diagnosis. Wang et al. [33] showed that DTI metrics 
and rCBV measurements could help in differentiating gliobla-
stomas, brain metastases, and PCLs. In another study conducted 
with DTI, Wang et al. [34] reported that fractional anisotropy 
and mean diffusivity classification models could increase 
diagnostic performance in the contrasted lesion of tumour in 
differentiating glioblastomas from brain metastases. Bauer et al. 
[35] showed that the combination of MR diffusion and perfusion 
parameters was superior to the use of any individual parameter 
in differentiating SBM from glioblastoma multiforme. To the 
best of our knowledge, in the differentiation between HGG and 
SBM, quantitative MR parameter combinations with combined 
ROC curve analysis provided by DWI, DSCI, and MRS were not 
used in any of the previous studies. Our study showed that in 
differentiating HGG from SBM, any of the model combinations 
in the peritumoural region (Figure 4) had a higher diagnostic 
accuracy than the individual use of any of the DWI, DSCI, and 
MRS parameters (Figures 3A, B, C). With ROC analysis, our stu-
dy showed that the best model that could differentiate HGG from 
SBM is the combination of peritumoural ADCmin, rCBV, and 
Cho/NAA parameters; the sensitivity, specificity, PPD, NPD, and 
AUC values were 94.1%, 100%, 100%, 97.4%, and 0.970, respec-
tively. The combination of quantitative information provided by 
peritumoural DWI, DSCI, and MRS with ROC analysis methods 
can better explain the underlying pathophysiology (unlike vaso-
genic oedema, infiltrative oedema has high cellularity, density, 
and neo-angiogenesis) in the peritumoural region used in the 
differentiation of these two tumours. Also, additional diagnostic 
information provided by each parameter can be combined for 
improved diagnostic performance. Therefore, this hypothesis is 
confirmed by the combination of parameters with ROC curve 
analysis in the peritumoural area. 
Limitations
Our study has some limitations. Firstly, as this work is 
a retrospective study, the ROIs placed in the enhancing tu-
mour and in the peritumoural region did not match with the 
tissue places sampled for histological analysis. Further pro-
spective studies that directly associate ROIs with histological 
observations are important, so that the DWI, DSCI, and MRS 
parameters can be more accurately interpreted. Secondly, this 
study has a small sample size. A large sample is required to 
confirm the results of our study. Thirdly, the signals of meta-
bolites could have been influenced by partial volume effects 
in some cases because of the effects of tumour heterogeneity. 
Lastly, we did not use absolute metabolite assessment methods. 
Conclusion
This study showed that the individual use of any of the 
peritumoral DWI, DSCI, and MRS parameters could be useful 
in differentiating between HGG and SBM. In differentiating 
HGG from SBM in the peritumoural region with ROC analysis, 
any of the model combinations was superior to any individual 
DWI, DSCI, and MRS parameter, and the best model found 
was the combination of peritumoural ADCmin, rCBV, and 
Cho/NAA, with 97% diagnostic accuracy. Therefore, the 
combination of peritumoural DWI, DSCI, and MRS para-
meters can provide more accurate diagnostic information in 
differentiating SBM from HGG. 
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